| Literature DB >> 35744650 |
Tawsif Ahmed Kazi1, Aparupa Acharya1, Bidhan Chandra Mukhopadhyay1, Sukhendu Mandal2, Ananta Prasad Arukha3, Subhendu Nayak4, Swadesh Ranjan Biswas1.
Abstract
Lactic acid bacteria (LAB) play a very vital role in food production, preservation, and as probiotic agents. Some of these species can colonize and survive longer in the gastrointestinal tract (GIT), where their presence is crucially helpful to promote human health. LAB has also been used as a safe and efficient incubator to produce proteins of interest. With the advent of genetic engineering, recombinant LAB have been effectively employed as vectors for delivering therapeutic molecules to mucosal tissues of the oral, nasal, and vaginal tracks and for shuttling therapeutics for diabetes, cancer, viral infections, and several gastrointestinal infections. The most important tool needed to develop genetically engineered LABs to produce proteins of interest is a plasmid-based gene expression system. To date, a handful of constitutive and inducible vectors for LAB have been developed, but their limited availability, host specificity, instability, and low carrying capacity have narrowed their spectrum of applications. The current review discusses the plasmid-based vectors that have been developed so far for LAB; their functionality, potency, and constraints; and further highlights the need for a new, more stable, and effective gene expression platform for LAB.Entities:
Keywords: NICE system; constitutive expression; lactic acid bacteria; plasmid-based vectors; rolling-circle replication; theta-mode of replication
Year: 2022 PMID: 35744650 PMCID: PMC9229153 DOI: 10.3390/microorganisms10061132
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Replicons used for the construction of vectors for LAB.
| Origin of Replication | Organism | Replication Type | Reference |
|---|---|---|---|
| pWV01 |
| Rolling circle | [ |
| pSH71 |
| Rolling circle | |
| pCI305 |
| Theta | |
| pAM |
| Theta |
Host and vectors engineered for the development of the NICE system.
|
|
|
|
| NZ9700 | Developed from conjugation between MG1614 (RifR StrpR derivative of MG1363) and nisin producer strain NIZO B8. Carries Tn5276 (nisin–sucrose transposon). Frequently used as a nisin producer strain for induction experiments. | [ |
| NZ9800 | Engineered from NZ9700 with a 4-bp deletion in the | |
| NZ9000 | ||
| NZ3000 | Derivative of the strain MG5267 with a partial deletion of the | |
| NZ3900 | Derivative of NZ3000; | |
| NZ9000- | NZ9000 with complete deletion of the | |
|
|
|
|
| pNZ9573 | Plasmid for | [ |
| pNZ9520 | ||
| pNZ9530 | ||
| pNZ8048 | Standard vector generally used for translational fusion at the | |
| pNZ8148 | Derived from pNZ8048 by a 60 bp deletion of the residual DNA from | |
| pNZ8150 | Standard vector generally used for translational fusion at the | |
| pNZ8021 | Vector for transcriptional fusions; CmR | |
| pNZ8110 | Standard vector used for protein secretion using the | |
| pNZ8008 | Promoterless | |
| pMSP3535 | Vector contains both |
Heterologous proteins produced in LAB using the plasmid-based gene expression system.
| Vector Used | Host Strain | Promoter | Product | Reference |
|---|---|---|---|---|
| pNZ8048 | Pnis | Intracellular rotavirus spike-protein subunit VP8 | [ | |
| pNZ8048 | P45 series | [ | ||
| pNZ8048 | PczcD | GFP | [ | |
| pNZ8048 | Pnis |
| [ | |
| pNZ8148 | Pnis | Heme oxygenase-1 | [ | |
| pNZ8048 |
| Pnis | [ | |
| pNZ8148 | Pnis | Pentadecapeptide BPC-157 | [ | |
| pNZ8148 | Pnis | Albumin binding domains | [ | |
| pNZ8148 | Pnis | p19-Thioredoxin fusion protein | [ | |
| pNZ273 | Pnis | [ | ||
| pOTHY12 | PthyA | Interleukin 10 (IL-10) | [ | |
| pRV300 | Pnis |
| [ | |
| pDK6 | Pnis | Elafin, Secretory Leukocyte Protease Inhibitor (SLPI) | [ | |
| pSEC | Pnis | Pancreatitis-associated protein I (PAP) | [ | |
| pFUN | Pzn |
| [ | |
| pAK80 | P170 | [ | ||
| pLB141 | PgroESL |
| [ | |
| pGEM | PxylT |
| [ | |
| pValac | PxylT | [ | ||
| pLB85 | PSPL | Ethanol | [ | |
| pSH71 | Pnis | IL-17, IL-23 | [ | |
| pT1NX | P1 | IL-27 | [ | |
| pAF100 |
| Papf | Antibody fragment | [ |
| pDL | Pnis | Protective | [ | |
| pSIP | PSPL | [ |